Endometrial intraepithelial neoplasia with secretory differentiation: diagnostic features and underlying mechanisms.

about

Endometrial intraepithelial neoplasia with secretory differentiation: diagnostic features and underlying mechanisms.

Item

http://www.wikidata.org/entity/Q53124115

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Endometrial intraepithelial ne ...... res and underlying mechanisms.

@en

Endometrial intraepithelial ne ...... res and underlying mechanisms.

@nl

type

Item

label

Endometrial intraepithelial ne ...... res and underlying mechanisms.

@en

Endometrial intraepithelial ne ...... res and underlying mechanisms.

@nl

prefLabel

Endometrial intraepithelial ne ...... res and underlying mechanisms.

@en

Endometrial intraepithelial ne ...... res and underlying mechanisms.

@nl

P1476

Endometrial intraepithelial ne ...... ures and underlying mechanisms

@en

P2093

George L Mutter

http://www.w3.org/2001/XMLSchema#string

Nicolas M Monte

http://www.w3.org/2001/XMLSchema#string

P2860

The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system

Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.

Endometrial hyperplasia with secretory changes.

Endometrial intraepithelial neoplasia: clinical correlates and outcomes.

Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia.

Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change.

Squamous morules are functionally inert elements of premalignant endometrial neoplasia.

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.

Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.

Involution of PTEN-null endometrial glands with progestin therapy.

P2888

modpathol.2012.231

P304

868-873

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2012.231

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Parra-Herran

P577

2013-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234161363

http://www.w3.org/2001/XMLSchema#string

P698

23328979

http://www.w3.org/2001/XMLSchema#string

P921

Endometrial intraepithelial neoplasia